State Ledger
Company profile

MEDICINOVA INC CIK 1226616

Ticker
MNOV (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
La Jolla, CA 92037
Fiscal year end
2025 (FY)
Market Data
Close
$1.55
Change
+$0.03
Change %
1.64%
Volume
5,012

MNOV · trading date Oct 12, 2026 · previous close $1.53 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$409.7K
Net income
-$12.00M
Total assets
$45.60M
Total liabilities
$4.02M
Stockholders' equity
$41.59M
Cash & equivalents
$30.81M
Operating income
-$13.28M
Operating cash flow
-$9.81M
Capital expenditures
$2.9K

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-3,242.5%
Net margin
-2,928.8%
Free cash flow
-$9.81M
Free cash flow margin
-2,395.4%
Liabilities / assets
8.8%
Equity / assets
91.2%
CapEx / revenue
0.7%
Operating cash flow / net income
0.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $409.7K -$12.00M $45.60M $4.02M $41.59M
2024 — -$11.05M $55.88M $3.37M $52.50M
2023 $1.00M -$8.57M $66.27M $3.89M $62.38M
2022 — -$14.07M $74.15M $3.91M $70.24M
2021 $4.04M -$10.13M $87.41M $3.73M $83.68M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-02
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
La Jolla, CA 92037
4275 EXECUTIVE SQUARE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:15 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies